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Abstract 
In long-term potentiation (LTP), one of the most studied types of neural plasticity, 
synaptic strength is persistently increased in response to stimulation. Although a 
number of different proteins have been implicated in the sub-cellular molecular 
processes underlying induction and maintenance of LTP, the precise mechanisms 
remain unknown. A particular challenge is to demonstrate that a proposed molecular 
mechanism can provide the level of stability needed to maintain memories for months or 
longer, in spite of the fact that many of the participating molecules have much shorter 
life spans. Here we present a computational model that combines simulations of several 
biochemical reactions that have been suggested in the LTP literature and show that the 
resulting system does exhibit the required stability. At the core of the model are two 
interlinked feedback loops of molecular reactions, one involving the atypical protein 
kinase PKMζ and its messenger RNA, the other involving PKMζ and GluA2-containing 
AMPA receptors. We demonstrate that robust bistability – stable equilibria both in the 
synapse’s potentiated and unpotentiated states – can arise from a set of simple 
molecular reactions. The model is able to account for a wide range of empirical results, 
including induction and maintenance of late-phase LTP, cellular memory reconsolidation 
and the effects of different pharmaceutical interventions. 
Keywords: LTP, PKMζ, PKMzeta, AMPAR, synaptic stability, reconsolidation, 
computational model 
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Author summary 
The brain stores memories by adjusting the strengths of connections between neurons, 
a phenomenon known as synaptic plasticity. Different types of plasticity mechanisms 
have either a strengthening or a weakening effect and produce synaptic modifications 
that last from milliseconds to months or more. One of the most studied forms of 
plasticity, long-term potentiation, is a persistent increase of synaptic strength that results 
from stimulation and is believed to play an important role in both short-term and long-
term memory. Researchers have identified many proteins and other molecules involved 
in long-term potentiation and formulated different hypotheses about the biochemical 
processes underlying its induction and maintenance. A growing number of studies 
support an important role for the protein PKMζ (protein kinase M Zeta) in long-term 
potentiation. To investigate the explanatory power of this hypothesis, we built a 
computational model of the proposed biochemical reactions that involve this protein and 
ran simulations of a number of experiments that have been reported in the literature. 
We find that our model is able to explain a wide range of empirical results and thus 
provide insights into the molecular mechanisms of memory. 
Introduction 
The brain stores memories by adjusting the strengths of connections between neurons. 
Such synaptic plasticity comes in different forms that strengthen or weaken synapses 
and range from very short-lived to long-lasting. One of the most well-studied forms of 
plasticity is long-term potentiation, LTP, a phenomenon whereby synaptic strength is 
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persistently increased in response to stimulation. Different forms of LTP are known to 
play important roles in both short-term and long-term memory. 
Many different proteins have been identified in the sub-cellular molecular processes that 
are involved in LTP. An important question is how these proteins, with lifetimes 
measured in hours or days, can maintain memories for months or years. We present a 
computational model that demonstrates how this problem can be solved by two 
interconnected feedback loops of molecular reactions.  
We begin with an overview of LTP with emphasis on the empirical findings that our 
model aims to explain. This is followed by a description of the model, an account of our 
results, and discussion of their implications. 
Background 
In his address to the Royal Society in 1894, Santiago Ramon y Cajal hypothesized that 
the brain stores information by adjusting the strengths of associations between neurons, 
as well as by growing new connections [1]. In the years since, the existence of both of 
these mechanisms, now known as synaptic plasticity and synaptogenesis, respectively, 
has been well established, and there is ample evidence that synaptic plasticity plays an 
important role in learning and memory [2–4]. 
Neurons communicate by transmitting signals across chemical synapses, where 
presynaptic axon terminals connect to postsynaptic neurons, most often on their 
dendrites. When a nerve impulse (action potential) arrives at the axon terminal, 
neurotransmitter molecules are released into the synaptic cleft, a narrow gap between 
the two neurons, where they activate receptors in the membrane of the postsynaptic 
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neuron. This sets in motion a series of biochemical events in the postsynaptic neuron, 
the details of which depend on the type of receptor, among other factors. Synaptic 
strength depends both on the amount of transmitter that is released by the arrival of a 
nerve impulse at the axon terminal and on the number and sensitivity of the receptors. It 
may thus be regulated on either the pre- or postsynaptic side, and mechanisms of 
synaptic plasticity have been shown to operate in both compartments [3]. Plasticity may 
either strengthen or weaken a synapse, and the effect may be short-lived or long-
lasting. Short-term synaptic plasticity, lasting from milliseconds to minutes, is primarily 
due to presynaptic mechanisms that adjust the amount of transmitter release, whereas 
postsynaptic modifications that adjust the number and sensitivity of receptors are 
important for long-term plasticity [4]. In particular, this is true of long-term potentiation 
(LTP), a type of persistent strengthening of synapses in response to stimulation [5,6], 
which has been studied extensively in the CA3-CA1 synapses of the rodent 
hippocampus [4] and is known to depend on an increase in the number of receptors 
inserted in the postsynaptic membrane [7].  
There are at least two forms of LTP: Moderately strong stimulation induces early-phase 
LTP (E-LTP), which persists for at most a few hours. When the stimulation is stronger, 
E-LTP may be followed by late-phase LTP (L-LTP), which can last for days, months or 
longer [7,8] and is believed to be an important mechanism for the storage of long-term 
memories [9,10]. The establishment of L-LTP, known as synaptic or cellular memory 
consolidation, is a process that takes less than an hour [11,12] and requires synthesis 
of new protein. This has been demonstrated by showing that infusion of protein-
synthesis-inhibiting drugs such as anisomycin can prevent establishment of L-LTP  [12–
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15]. On the behavioral level, protein synthesis inhibition (PSI) has been shown to impair 
the formation of long-term memory, consistent with the notion of L-LTP as a memory 
mechanism [16]. 
Once long-term memory is established, it is in general no longer vulnerable to infusion 
of a protein synthesis inhibitor [16]. However, memory retrieval can induce a state of 
transient instability, during which the memory is again susceptible to protein synthesis 
inhibition [17–19]. This susceptibility of memory to post-retrieval PSI infusion has been 
shown to correlate with instability of L-LTP at the neural level [20,21], providing further 
evidence of the importance of LTP as a mechanism of long-term memory. The synaptic 
destabilization that is triggered by memory retrieval is followed by a period of 
restabilization which has similarities with the initial synaptic consolidation that follows 
memory acquisition. It has therefore become known as memory reconsolidation [19], 
more specifically synaptic (or cellular) reconsolidation, to avoid confusion with the 
related but distinct phenomenon systems reconsolidation, a temporary dependence on 
the hippocampus for restabilization of a memory after reactivation (retrieval). For 
reviews of reconsolidation research, see [22–24]. For a computational model of systems 
consolidation and reconsolidation, see [25]. 
Glutamatergic synapses 
In this report, we focus on L-LTP induction and maintenance at glutamatergic synapses, 
the most abundant type of synapse in the vertebrate nervous system [26,27]. 
Glutamatergic synapses contain several kinds of receptors that are activated by the 
neurotransmitter glutamate. Of particular interest for LTP are the α-amino-3-hydroxy-5-
methyl-4-isoxazolepropionic acid receptor (AMPA receptor or AMPAR), which mediates 
 7 
 
synaptic transmission [28], and the N-methyl-D-aspartate receptor (NMDA receptor or 
NMDAR), which is involved with regulatory functions including the regulation of synaptic 
strength [29,30]. 
AMPARs are ion channels that open when activated by the neurotransmitter glutamate. 
The opening of the channel allows positively charged ions, mainly sodium and 
potassium, to flow through the cell membrane [31]. This causes a partial depolarization 
of the membrane, which at rest is polarized by a net negative charge inside the cell. The 
partial depolarization is known as an excitatory postsynaptic potential, or EPSP, and the 
amplitude of the EPSP produced by a single action potential arriving at a synapse is a 
measure of synaptic strength. Among other factors, the EPSP amplitude depends on 
the number of AMPARs inserted in the postsynaptic density (PSD), the area of cell 
membrane that constitutes the receiving side of the synapse [31]. Thus mechanisms 
that control the trafficking of AMPARs into and out of the PSD play an important part in 
the regulation of synaptic strength. 
AMPARs are heterotetramers, i.e. they consist of four non-identical subunits. The 
subunits are of four different kinds, named GluA1, GluA2, GluA3 and GluA4, and 
AMPARs can be made up of different combinations of these [32]. GluA2 is of particular 
interest here, because L-LTP is associated with an increase in the number of GluA2-
containing AMPARs inserted in the PSD [20,33,34]. 
AMPA receptors are not permanently inserted in the PSD, but are constantly being 
recycled. Certain proteins transport AMPARs into the PSD from pools maintained in 
adjacent areas, while others remove them (a process known as internalization or 
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endocytosis) and either recycle them to stand-by pools or mark them for degradation 
[35,36]. 
Protein kinase M zeta (PKMζ) 
Many proteins have been implicated in the induction and maintenance of LTP, including 
CaMKII, PKA, MAPK and several isoforms of PKC (for a review, see [7]). An atypical 
isoform of PKC, protein kinase Mζ (PKMζ), is believed to play an important role for 
L-LTP. The level of PKMζ has been shown to increase as the result of NMDA receptor 
stimulation [37,38], consistent with its proposed role in L-LTP induction. Inhibition of 
PKMζ activity results in disruption of established L-LTP [39–41], and perfusion of PKMζ 
into a neuron can induce L-LTP [39] . PKMζ activity is believed to increase the number 
of inserted GluA2-containing AMPARs at the synapse both by facilitating the trafficking 
of these receptors into the PSD and by inhibiting their removal [42]. GluA2-containing 
AMPARs are held at extrasynaptic pools by the protein PICK1 which binds to the GluA2 
subunit [34]. PKMζ facilitates interaction between the trafficking protein NSF and the 
GluA2 subunit, which results in its release from PICK1, freeing the AMPARs to diffuse 
laterally into the PSD [34]. Furthermore, once GluA2-containing AMPARs are inserted in 
the PSD membrane, PKMζ prevents their removal by inhibiting the interaction between 
the protein BRAG2 and the GluA2 subunit [43], an interaction that plays a key part in 
endocytosis of GluA2-containing AMPARs [42,44]. 
While GluA2-containing AMPARs are important for the stabilization of L-LTP, there is 
evidence that GluA2-lacking AMPARs play an important role in the induction of early-
phase LTP (E-LTP), and also in reconsolidation. Several studies have shown that 
GluA2-lacking AMPARs are initially inserted at the time of memory acquisition or LTP 
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induction, and then gradually replaced by GluA2-containing AMPARs during 
consolidation [45–47]. Hong et al. [20] showed that memory reactivation triggers an 
abrupt replacement of GluA2-containing AMPARs by GluA2-lacking AMPARs. This is 
followed by a gradual reversal, i.e. the GluA2-containing AMPARs are restored and the 
number of GluA2-lacking AMPARs declines, as the potentiated state of the synapse is 
restabilized [20]. Because the temporary removal of GluA2-containing AMPARs is 
compensated for by an increase in GluA2-lacking AMPARs, the synaptic strength 
remains more or less constant during the period of instability [20]. Rao-Ruiz et al. [21] 
reported similar results, although they observed a brief period of reduced synaptic 
strength between the GluA2-containing AMPAR removal and GluA2-lacking AMPAR 
insertion. Taken together, these results suggest that the stabilization of LTP, both 
initially during consolidation, and after reactivation-induced destabilization, requires 
insertion of GluA2-containing AMPARs, and that PKMζ plays an important role in 
maintaining the GluA2-containing AMPARs at the synapse. 
An important question is how L-LTP, which can last for months or longer [8], can be 
maintained by a protein like PKMζ, with a half-life that probably does not exceed several 
hours or at most a few days [48–51]. A proposed answer to this question involves local 
translation of messenger RNA (mRNA) in or near dendritic spines. Most synapses are 
formed at dendritic spine heads, with one synapse per spine [52]. It has been shown 
that PKMζ mRNA is transported from the cell body to dendrites [53,54], but the mRNA 
in its basal state is translationally repressed by molecules that bind to it, or to the 
complex of proteins required to initiate translation [50,53,55]. There is evidence that 
PKMζ catalyzes reactions that lift this translational block [49,56], possibly through 
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inhibition of the PIN1 protein [42], resulting in a positive feedback loop [49]. By 
promoting its own synthesis in this manner, PKMζ may be able to remain at an 
increased level, and thus maintain L-LTP, for a long time, perhaps indefinitely. 
It has also been suggested that the increased amount of inserted GluA2-containing 
AMPARs at a potentiated synapse captures the PKMζ molecules and keeps them from 
dissipating away from the synaptic compartment [42]. This hypothesis is supported by 
several studies that show that blocking endocytosis of GluA2-containing AMPARs can 
prevent depotentiation under protocols that otherwise cause disruption of L-LTP 
[21,33,57]. Together with PKMζ’s inhibiting effect on AMPAR endocytosis this 
constitutes a second feedback loop, a reciprocal relationship in which PKMζ and GluA2-
containing AMPARs prevent each other’s removal from the synapse. As we shall see, 
the interaction between these two feedback loops plays a central role in our explanation 
of synaptic bistability, that is that synapses have two stable equilibrium states, 
unpotentiated and potentiated. Transient stimuli can cause a synapse to transition 
between these two states, but in the absence of such signals it tends to remain in one 
state or the other. 
L-LTP, LTM and pharmacological interventions 
The notion that L-LTP is an important neural correlate of long-term memory (LTM) has 
been supported experimentally by demonstrating that pharmacological interventions 
that block L-LTP induction also interfere with the establishment of LTM [58], and that 
interventions that disrupt established L-LTP also impair consolidated memories [59]. 
Here we consider three types of pharmaceuticals that have been shown to produce 
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significant results with respect to both L-LTP induction and maintenance, and to related 
behavior-level memory phenomena. 
Protein synthesis inhibitors. Infusion of protein synthesis inhibitors (PSIs) such as 
anisomycin into brain tissue can prevent the induction of L-LTP [58], and also interferes 
with memory consolidation, the establishment of LTM [60,61]. Once L-LTP is 
established, it becomes resistant to infusion of anisomycin [11,12]. This does not mean 
that L-LTP can be maintained indefinitely without ongoing protein synthesis, but rather 
that it can tolerate an interruption of protein synthesis for the amount of time that 
anisomycin remains active after infusion. 
Reactivation of a consolidated memory, e.g. by a reminder, can temporarily return it to a 
labile state in which it is again vulnerable to PSI infusion [18,60]. The putative molecular 
process underlying this phenomenon has been termed cellular or  synaptic memory 
reconsolidation [18,62]. Concordant with the hypothesis that L-LTP is the neural 
correlate of LTM, the temporary post-reactivation vulnerability of LTM to PSI infusion 
can be explained as destabilization of L-LTP, followed by a restabilization phase that 
requires protein synthesis, hence the susceptibility to PSI. The destabilization has been 
shown to require the activity of NMDA receptors [29], and to depend critically on 
endocytosis of GluA2-containing AMPARs [57,63]. 
Thus protein synthesis inhibition is known to both prevent establishment of L-LTP and to 
block reconsolidation, i.e. block restabilization of L-LTP after retrieval-induced 
destabilization. 
ZIP. Much of the work demonstrating the role of PKMζ in L-LTP is based on 
administration of the synthetic peptide ZIP (zeta-inhibitory peptide), which binds to the 
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catalytic region of the PKMζ molecule, thus blocking its enzymatic activity [41]. On the 
behavioral level, infusion of ZIP into brain tissue has been shown to impair consolidated 
LTM [59]. On the neural level, ZIP is known to disrupt established L-LTP when applied 
during the maintenance phase [39–41,64]. These results are consistent with the notion 
of a positive feedback loop: Inhibiting PKMζ’s enzymatic activity prevents it from 
catalyzing its own synthesis; the PKMζ concentration then drops, the AMPAR 
endocytosis rate increases, and the synapse returns to its basal state. On the other 
hand, ZIP does not prevent L-LTP induction when applied only during or immediately 
after stimulation. This was demonstrated by Ren et al. [65] in an in-vitro experiment 
where onset and duration of ZIP application were precisely controlled. 
GluA23Y. GluA23Y is a synthetic peptide that blocks regulated endocytosis of GluA2-
containing AMPARs [66,67]. Infusion of GluA23Y has been shown to block both the 
destabilizing effect of PSI infusion after memory reactivation [20,57] and the 
depotentiating effect of ZIP during L-LTP maintenance [33]. The GluA23Y peptide is 
modeled on a sequence of the GluA2 subunit’s carboxyl tail and its endocytosis-
inhibiting effect is believed to be due to competitive disruption of the binding of 
endocytosis-related proteins to this sequence on GluA2 subunits [68]. 
Computational model 
The findings described above suggest a model of L-LTP maintenance with two 
connected feedback loops: (1) PKMζ maintains its own mRNA in a translatable state 
and translation of the mRNA in turn replenishes PKMζ. (2) PKMζ maintains GluA2-
containing AMPARs at the synapse, and these in turn keep PKMζ molecules from 
dissipating away from the synaptic compartment. Below we describe a computational 
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model that incorporates these relationships and investigate its ability to account for 
results reported in the empirical literature. 
Methods 
Deterministic vs. stochastic simulation  
Systems of chemical reactions can be modeled either by deterministic methods based 
on ordinary differential equations (ODEs) or by stochastic simulation. When the 
numbers of molecules are small, stochastic simulation is the better choice, because 
random fluctuations then have significant effects that are not captured by deterministic 
methods [69]. In particular, random fluctuations can cause a small system to 
spontaneously transition from one steady state to another; the resulting impact on 
system stability can be studied in a stochastic simulation, but not in a deterministic 
model [70], because the latter only accounts for average reaction rates over a large 
number of molecules. 
The molecules of interest for our simulation are present in small numbers in a dendritic 
spine head, e.g. fewer than a hundred PKMζ molecules (see S1 Text) and at most ca 
150 AMPARs [71,72]. This is well below the size of system that can be realistically 
simulated by deterministic methods [70,73]. We therefore base our simulation on the 
Gillespie algorithm [74], a well-established and widely used approach to discrete and 
stochastic simulation of reaction systems [69,70,73]. 
Model description 
The model consists of four inter-dependent pairs of processes (see Fig 1): 
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Fig 1: Process diagram. a) Activation/deactivation of PKMζ mRNA (blue). 
Translational repression of mRNA is lifted by catalytic activity of PKMζ, possibly by 
phosphorylation of mRNA-binding proteins. A phosphatase (pink) dephosphorylates the 
same proteins, returning mRNA to its repressed state. b) Synthesis and 
degradation/dissipation of PKMζ (cyan). Synthesis consists in local translation of PKMζ 
mRNA. Degradation and/or dissipation away from the synaptic compartment is inhibited 
by inserted GluA2-containing AMPARs. c) Trafficking of GluA2-containing AMPARs 
(green) into and out of the PSD. Insertion is facilitated by PKMζ, and removal 
(endocytosis) by the BRAG2 protein. d) Inhibition/disinhibition of BRAG2-GluA2 
interaction. Inhibition is modeled as phosphorylation of BRAG2 (orange) catalyzed by 
PKMζ, and disinhibition as dephosphorylation catalyzed by a phosphatase. E1 and E2 
(dark green) are enzymes activated by NMDAR stimulation at L-LTP induction and 
memory reactivation, respectively. The effects of PSI, ZIP and GluA23Y (red) are 
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modeled by disabling the indicated catalytic reactions. Solid arrows represent chemical 
reactions and receptor trafficking. Dashed lines with filled circles represent catalytic 
activity. Dashed lines with crossbars represent inhibition. 
Activation/deactivation of PKMζ mRNA. PKMζ lifts the constitutive translational 
repression of PKMζ mRNA by phosphorylating some substrate, possibly mRNA-binding 
proteins attached to the mRNA. The mRNA molecule with attached proteins and 
ribosomes (polysome) is represented as a single molecule in the model, and de-
repression is modeled as phosphorylation of (some component of) this molecule by 
PKMζ. The opposite reaction, dephosphorylation by a phosphatase assumed to be 
present at fixed concentration, returns the mRNA to its repressed state. 
Synthesis and degradation/dissipation of PKMζ. Synthesis consists in local 
translation of PKMζ mRNA. (This is somewhat speculative: PKMζ mRNA has been 
shown to be present in dendrites [53,54], but not specifically in dendritic spines.) 
Inserted GluA2-containing AMPARs inhibit degradation and/or dissipation of PKMζ 
away from the synaptic compartment by binding PKMζ molecules [42], probably via a 
scaffold protein such as PICK1 or KIBRA [75]. This is modeled as an affinity of PKMζ for 
inserted GluA2-containing AMPARs, with a reduced dissipation/degradation rate while 
so attached.  
GluA2-containing AMPAR trafficking into and out of the PSD. The model includes a 
fixed-size population of GluA2-containing AMPARs. At any time, a subset of the 
AMPARs are inserted in the PSD while the remainder are maintained in extrasynaptic 
pools. Transport of AMPARs into the PSD is facilitated by PKMζ and removal 
(endocytosis) is enabled by the protein BRAG2. In addition to these two regulated 
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processes, constitutive processes traffic AMPARs into and out of the synapse at lower 
rates. 
Inhibition and disinhibition of BRAG2-GluA2 interaction. The mechanism by which 
PKMζ inhibits the interaction between BRAG2 and the GluA2 subunit to block AMPAR 
removal from the PSD is not known, but presumably involves phosphorylation of some 
substrate. We model the inhibition as phosphorylation of the BRAG2 molecule itself; 
other possibilities include phosphorylation of a site on the GluA2 subunit or of another 
participating protein. The BRAG2-GluA2 interaction is restored through 
dephosphorylation of the same substrate by a phosphatase, which is assumed to be 
present in fixed concentration. 
Although the increase in PKMζ level that is associated with L-LTP induction is known to 
depend on NMDAR activation [38], the underlying biochemical pathways are unknown. 
In the model this mechanism is represented by an unspecified enzyme that we call E1 
which, when activated by a reaction cascade triggered by NMDAR activation, has the 
ability to lift the translational block on PKMζ mRNA, thereby enabling PKMζ synthesis. 
Similarly, the destabilizing effect of memory reactivation has been shown to depend on 
NMDAR activity and on endocytosis of GluA2-containing AMPARs [20,57,76], but the 
biochemical cascades that connect these event have not yet been identified. In our 
model, reactivation is simulated as an increase in the level of a second unspecified 
enzyme E2 with the ability to catalyze endocytosis of GluA2-containing AMPAR.  
In addition to these processes, the model includes simulation of the effects of the three 
pharmaceuticals described in the introduction. The time intervals that these drugs 
remain at a high enough concentration to inhibit their targets depend on the doses 
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infused and also on their specific rates of decay or metabolism. The intervals used here 
are based on activity periods reported in the cited references: 
PSI: Infusion of a protein synthesis inhibitor is simulated by disabling PKMζ synthesis 
for nine hours, the amount of time that the protein synthesis inhibitor anisomycin 
remains active after infusion into brain tissue [77]. 
ZIP: Administration of the ZIP peptide is simulated by disabling PKMζ’s enzymatic 
activity – catalysis of mRNA activation, facilitation of GluA2-containing AMPAR 
trafficking into the PSD and inhibition of BRAG2-GluA2 interaction – for twelve hours 
[78]. 
GluA23Y: Perfusion of GluA23Y is simulated by disabling regulated endocytosis of 
GluA2-containing AMPAR for twelve hours [76]. (GluA23Y does not affect constitutive 
endocytosis of GluA2-containing AMPAR [67].) 
Table 1 lists the molecule species included in the model, including complexes formed 
during enzymatic reactions. All simulations begin in the lower (unpotentiated) steady 
state with the indicated initial molecule counts. 
Table 1: Molecule species 
Symbol Description Initial 
count 
P Unbound PKMζ 0 
RI unphosphorylated PKMζ mRNA 
(inactive) 
100 
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RA phosphorylated PKMζ mRNA (active) 0 
PP phosphatase 100 
PP RA PP + RA complex 0 
E1A E1 enzyme, active 0 
E1I E1 enzyme, inactive 100 
E1A RI E1A + RI complex 0 
AU Uninserted GluA2-containing AMPAR 100 
AI Inserted GluA2-containing AMPAR 0 
AI P PKMζ bound to inserted AMPAR 0 
P RI P + RI complex  0 
AI P RI AI + P + RI complex  0 
BA Active BRAG2 100 
BI Inactive BRAG2 0 
PP BI PP + BI complex 0 
P BA P + BA complex  0 
AI P BA AI + P + BA complex  0 
BA AI BA + AI complex 0 
BA AI P BA + AI + P complex 0 
 19 
 
E2A E2 enzyme, active 0 
E2I E2 enzyme, inactive 100 
Simulated Reactions 
Activation of PKMζ mRNA. PKMζ mRNA is present in dendritic spines, but is 
translationally repressed in its basal state [42,53] due to mRNA-binding proteins that 
prevent translation from being initiated [55]. PKMζ is able to lift the repression, possibly 
by phosphorylating these proteins, thus catalyzing its own synthesis in a positive 
feedback loop. We model mRNA with its associated proteins as a single molecule, 
represented by RI in its inactive repressed state, and by RA when activated. Activation is 
modeled using Michaelis-Menten kinetics [73], i.e. a PKMζ molecule (P) and an inactive 
mRNA molecule (RI) form a complex P•RI. The complex may then either dissociate 
(reaction 2) or the catalytic reaction (3) may take place, producing active mRNA (RA):   
1 •cI IP R P R   (1)  
2• cI IP R P R   (2)  
3• cI AP R P R   (3)  
Deactivation of PKMζ mRNA. The PKMζ mRNA returns to its repressed state when 
the mRNA-binding proteins are dephosphorylated by a phosphatase which we denote 
by PP. This is also modeled with Michaelis-Menten kinetics (as are all enzymatic 
reactions in the model):  
4c
A APP R PP R   
(4)  
5c
A APP R PP R   
(5)  
6c
A IPP R PP R   
(6)  
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PKMζ synthesis and degradation/dissipation. PKMζ is synthesized by local 
translation of active mRNA (reaction 7). Over time PKMζ degrades or diffuses away 
from the synaptic compartment. Reaction 8 represents the combined effect of these two 
processes. The model is unspecific with respect to their relative importance for PKMζ 
turnover. 
7c
A AR R P   
(7)  
8 0
c
P  (8)  
Inhibition/disinhibition of BRAG2. BRAG2 is inhibited by PKMζ and reactivated by 
phosphatase. Both processes are described by Michaelis-Menten kinetics. BA and BI 
denote active and inhibited BRAG2, respectively: 
9c
A AP B P B   
(9)  
10c
A AP B P B   (10)  
11c
A IP B P B   (11)  
  
12c
I IPP B PP B   
(12)  
13c
I IPP B PP B   (13)  
14c
I APP B PP B   (14)  
AMPA receptor trafficking. Transport of GluA2-containing AMPARs into the PSD has 
been shown to involve a trafficking process that is facilitated by PKMζ [34]. Because the 
details of this process are unknown, including which substrate of PKMζ mediates it, we 
model it as a simple enzymatic reaction wherein PKMζ catalyzes the conversion of an 
uninserted GluA2-containing AMPAR, AU, to an inserted one, AI. 
15c
U UP A A P   
(15)  
16.
c
U UA P P A   
(16)  
17.
c
U IA P P A   
(17)  
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The protein BRAG2 catalyzes endocytosis of GluA2-containing AMPARs, removal from 
the PSD. 
18c
A I A IB A B A   
(18)  
19c
A I A Ì
B A B A   (19)  
20c
A I A UB A B A   
(20)  
A pair of unregulated processes maintain background cycling of GluA2-containing 
AMPARs into and out of the PSD: 
21c
U IA A  
(21)  
22c
I UA A  (22)  
Sequestering of PKMζ in the synaptic compartment. Our model implements the 
notion suggested by Sacktor [42] and supported by empirical results [20,33,57], that 
GluA2-containing AMPARs, when inserted in the PSD, prevent diffusion of PKMζ 
molecules away from the synapse and/or slows down degradation of PKMζ. We model 
this as a PKMζ molecule binding to an inserted GluA2-containing AMPAR to form a 
complex AI•P (reaction 23) and by bound PKMζ having a much lower rate of 
dissipation/degradation than free PKMζ (c24 << c8): 
23c
I IP A A P   
(23)  
24c
I IA P A  
(24)  
The AI•P complex is dissolved if the GluA2-containing AMPAR is removed from the 
membrane by BRAG2 or constitutively: 
25c
A I A IB A P B A P   
(25)  
26c
A I A IB A P B A P   
(26)  
27c
A I A UB A P B A P    
(27)  
28c
I uA P A P   (28)  
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PKMζ remains catalytically active while sequestered by GluA2-containing AMPARs, 
thus the reactions catalyzed by free PKMζ (reactions 1-3 and 9-11) are also catalyzed 
by PKMζ when it is bound to AI: 
29c
I I I IA P R A P R   
(29)  
30c
I I I IA P R A P R   
(30)  
31c
I I I AA P R A P R   (31)  
  
32c
I A I AA P B A P B   
(32)  
33c
I A I AA P B A P B   (33)  
34c
I A I IA P B A P B   (34)  
NMDAR stimulation. The mechanism by which NMDAR activation causes an increase 
in PKMζ is unknown. We model the effect of strong NMDAR stimulation as a rapid 
increase in the number of active molecules of an unspecified enzyme E1 which, like 
PKMζ, activates PKMζ mRNA. E1I and E1A represent the E1 enzyme in its active and 
inactive states, respectively: 
351 1
c
A I A IE R E R   
(35)  
361 1
c
A I A IE R E R   
(36)  
371 1
c
A I A AE R E R   (37)  
The E1 enzyme spontaneously deactivates at a rate that is specified by the reaction 
constant c38: 
381 1
c
A IE E  
(38)  
Reactivation. Reactivation of a consolidated memory causes it to become destabilized 
[18,79,80]. The molecular mechanism underlying this destabilization is not well 
understood, but has been showed to depend critically on endocytosis of GluA2-
containing AMPAR [20,57,63]. We model the destabilizing effect of reactivation as an 
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increase in the number of molecules of a second unspecified enzyme, E2, which 
catalyzes AMPAR endocytosis: 
392 2
c
A I A UE A E A    
(39)  
402 2
c
A I A UE A P E A P     
(40)  
As in the case of BRAG2-catalyzed endocytosis (reaction 27), the AMPAR/PKMζ 
complex dissolves when the AMPAR is endocytosed (reaction 40). 
The E2 enzyme spontaneously deactivates at a rate that is specified by the reaction 
constant c41: 
412 2
c
A IE E  
(41)  
Protein synthesis inhibition. The effect of PSI infusion is simulated by disabling 
synthesis of PKMζ (reaction 7). 
Inhibition of PKMζ by ZIP. The effect of ZIP infusion is simulated by disabling all PKMζ 
enzymatic activity (reactions 1, 9, 15, 29 and 32). 
Inhibition of AMPAR endocytosis by GluA23Y. The effect of GluA23Y infusion is 
simulated by disabling regulated AMPAR endocytosis, whether catalyzed by BRAG2 
(reactions 18 and 25) or by the E2 enzyme (reactions 39 and 40). 
The simulated reactions are summarized in Table 2. Reaction rates are controlled by 
Gillespie reaction constant, c1, c2, etc., such that ci dt is the average probability that a 
particular combination of the reactant molecules of reaction i will react during the next 
infinitesimal time interval dt [74]. The values for the reaction constants have been 
selected so that the model’s behavior approximates the observed time courses of the 
simulated experiments; see cited references in the description of each simulation. 
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Table 2: Simulated reactions 
 Reaction Description ci (s-1) 
 1  1 •cI IP R P R   
Formation of P•RI complex 10.0 
 2  2• cI IP R P R   
Dissolution of P•RI complex 400.0 
 3  3• cI AP R P R   
Activation of PKMζ mRNA, catalyzed by 
PKMζ 
100.0 
 4  4c
A APP R PP R   
Formation of PP•RA complex 4.0 
 5  5c
A APP R PP R   
Dissolution of PP•RA complex 400.0 
 6  6c
A IPP R PP R   
Deactivation of PKMζ mRNA, catalyzed by 
phosphatase 
100.0 
 7  7c
A AR R P   
Translation of PKMζ mRNA 0.2 
 8  8 0cP  PKMζ degradation or dissipation 0.65 
 9  9c
A AP B P B   
Formation of P•BA complex 1.0 
 10  10c
A AP B P B   
Dissolution of P•BA complex 400.0 
 11  11c
A IP B P B   
Inhibition of BRAG2, catalyzed by PKMζ 20.0 
 12  12c
I IPP B PP B   
Formation of PP•BI complex  1.0 
 13  13c
I IPP B PP B   
Dissolution of PP•BI complex 400.0 
 14  14c
I APP B PP B   
Disinhibition of BRAG2, catalyzed by 
phosphatase 
0.06 
 15  15c
U UP A A P   
Formation of P•AU complex 0.4 
 16  16.
c
U UA P P A   
Dissolution of P•AU complex 400.0 
 17  17.
c
U IA P P A   
PKMZ-catalyzed trafficking of GluA2-
containing AMPAR into the PSD 
20.0 
 18  18c
A I A IB A B A   
Formation of BA•AI complex 10.0 
 19  19c
A I A Ì
B A B A   Dissolution of BA•AI complex 400.0 
 20  20c
A I A UB A B A   
BRAG2-catalyzed endocytosis of GluA2-
containing AMPAR 
4.0 
 21  21c
U IA A  
Unregulated trafficking of GluA2-containing 
AMPAR into the PSD 
0.05 
 22  22c
I UA A  
Unregulated removal GluA2-containing 
AMPAR from the PSD 
0.005 
 23  23c
I IP A A P   
Inserted GluA2-containing AMPAR binds 
PKMζ 
1.0 
 24  24c
I IA P A  
Degradation of PKMζ bound to inserted 
AMPAR 
0.0001 
 25  25c
A I A IB A P B A P   
Formation of BA•AI•P complex 10.0 
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 26  26c
A I A IB A P B A P   
Dissolution of BA•AI•P complex 400.0 
 27  27c
A I A UB A P B A P    
BRAG2-catalyzed endocytosis of GluA2-
containing AMPAR with bound PKMζ. 
4.0 
 28  28c
I uA P A P   Unregulated endocytosis of GluA2-containing 
AMPAR with bound PKMζ. 
0.005 
 29  29c
I I I IA P R A P R   
Formation of AI•P•RI complex 10.0 
 30  30c
I I I IA P R A P R   
Dissolution of AI•P•RI complex 400.0 
 31  31c
I I I AA P R A P R   Activation of PKMζ mRNA, catalyzed by 
AMPAR-bound PKMζ 
100.0 
 32  32c
I A I AA P B A P B   
Formation of AI•P•BA complex 1.0 
 33  33c
I A I AA P B A P B   Dissolution of AI•P•BA complex 400.0 
 34  34c
I A I IA P B A P B   Inhibition of BRAG2, catalyzed by AMPAR-
bound PKMζ 
20.0 
 35  351 1
c
A I A IE R E R   
Formation of E1A•RI complex 10.0 
 36  361 1
c
A I A IE R E R   
Dissolution of E1A•RI complex 400.0 
 37  371 1cA I A AE R E R   Activation of PKMζ mRNA, catalyzed by E1 
enzyme 
100.0 
 38  381 1
c
A IE E  
Spontaneous deactivation of E1 enzyme 0.3 
 39  392 2
c
A I A UE A E A    
Endocytosis of GluA2-containing AMPAR, 
catalyzed by E2 enzyme 
0.1 
 40  402 2
c
A I A UE A P E A P     
E2-catalyzed endocytosis of GluA2-
containing AMPAR with bound PKMζ 
0.1 
 41  412 2
c
A IE E  
Spontaneous deactivation of E2 enzyme 0.5 
Simulation environment 
The model is implemented as a C++ program and all simulations were executed on an 
Intel i5-2400 computer running the Debian Linux 8.4 operating system. 
Objectives 
Our computational model simulates the regulation of PKMζ concentration at the 
postsynaptic density and its role in the induction and maintenance of L-LTP. The goal 
for the model is to simulate the empirical results described in the introduction and 
summarized in Table 3 below. Most of the cited results are from studies of Schaffer 
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collateral synapses on CA1 pyramidal neurons in the rat or mouse hippocampus, a few 
refer to unspecified hippocampal regions or amygdala of rat or mouse. 
Table 3: Simulation objectives 
 Result Description Citations 
1 Induction by NMDAR 
stimulation  
Strong NMDAR stimulation 
induces L-LTP 
[40,81] 
2 PSI blocks NMDAR-
triggered L-LTP 
induction 
Infusion of protein synthesis 
inhibitors prevents L-LTP 
induction by NMDAR 
stimulation 
[9,82] 
3 ZIP during stimulation 
does not prevent 
L-LTP induction 
ZIP treatment during and 
immediately after 
stimulation does not prevent 
establishment of L-LTP 
[65] 
4 Induction by PKMζ 
perfusion  
Perfusion of PKMζ into a 
neuron induces L-LTP 
[39,83] 
5 PSI does not disrupt 
established L-
LTP/LTM 
Application of a protein 
synthesis inhibitor during 
L-LTP maintenance (without 
preceding reactivation) does 
not cause disruption of L-
LTP 
[12,18,79] 
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6 Reactivation does not 
disrupt LTM 
Memory reactivation does 
not by itself disrupt LTM 
[18,79] 
7 Reactivation followed 
by PSI infusion does 
disrupt LTM 
PSI administered within a 
time window after 
reactivation disrupts LTM 
[18,79] 
8 GluA23Y blocks the 
LTM-disrupting effect 
of PSI  
GluA23Y administered 
together with PSI after 
reactivation blocks the LTM-
disrupting effect of PSI 
[20,57,63] 
9 ZIP disrupts 
established L-LTP  
Infusion of ZIP during the 
maintenance phase disrupts 
L-LTP 
[39–41] 
10 GluA23Y blocks the 
depotentiating effect 
of ZIP 
GluA23Y infused together 
with ZIP prevents 
depotentiation of 
established L-LTP 
[33] 
Results 
In the following plots of simulation results, P denotes the total number of PKMζ 
molecules in the synaptic compartment, whether free or bound to a substrate or to an 
AMPAR (see Table 1), and AI denotes the number of AMPARs inserted in the PSD, with 
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and without bound PKMζ molecules. Reaction numbers refer to the reactions described 
in Table 2. 
NMDAR stimulation induces L-LTP 
We model the result of strong NMDAR stimulation as a rapid increase of the population 
of active E1 enzyme molecules. This causes the translational repression of PKMζ 
mRNA to be lifted (reactions 35-37) and synthesis of PKMζ to start (reaction 7). Fig 2 
shows a trace of the number of PKMζ molecules, active PKMζ mRNA molecules and 
GluA2-containing AMPARs inserted in the PSD during a single simulation run.  
 
Fig 2: L-LTP induction, single simulation trace. NMDAR stimulation is simulated by 
instantaneous activation of 100 E1 molecules at “Stim”. E1 lifts the translational 
inhibition of PKMζ mRNA, synthesis of PKMζ starts, PKMζ drives up the number of 
inserted GluA2-containing AMPARs, and the synapse switches to its potentiated steady 
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state. RA: active PKMζ mRNA, P: PKMζ, AI: inserted GluA2-containing AMPARs, E1A: 
activated E1 enzyme. 
The model has two stable states: an unpotentiated state in which there are very few 
active mRNA molecules, PKMζ molecules and inserted GluA2-containing AMPARs, and 
a potentiated state with significantly higher levels of each of these molecules. The brief 
spike of E1 enzyme lifts the translational repression of enough PKMζ mRNA molecules 
to trigger a transition to the potentiated state. Although the molecule numbers fluctuate 
in the potentiated state, it is in fact very stable: No spontaneous depotentiation events 
are observed even when the model is allowed to run for a full year of simulated time. 
Fig 3 shows mean molecule counts for 100 simulations of L-LTP induction. It takes the 
model between 30 and 60 minutes of simulated time to complete the switch to its upper 
(potentiated) steady state in which there is a high number of inserted GluA2-containing 
AMPARs. This is consistent with the observed duration of the cellular consolidation 
window [16,58]. 
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Fig 3: L-LTP induction. The same simulation as in Fig 2, but here solid lines represent 
mean molecule counts for 100 simulations. Lightly colored bands indicate standard 
deviation. NMDA stimulation triggers a brief spike of E1 activity that activates PKMζ 
mRNA. This is followed by a slight decline in the number of active mRNA molecules, 
until the growing amount of PKMζ drives it back up and an equilibrium is reached. RA: 
active PKMζ mRNA, P: PKMζ, AI: inserted GluA2-containing AMPARs, E1A: activated 
E1 enzyme. 
PSI prevents L-LTP induction 
Simulated PSI infusion prevents NMDAR stimulation from inducing L-LTP, (Fig 4). 
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Fig 4: PSI prevents NMDAR stimulation from inducing L-LTP. E1A enzyme activates 
PKMζ mRNA, but PSI prevents PKMζ synthesis and when the E1 enzyme becomes 
inactivate, phosphatase returns the mRNA to its inhibited state. Solid lines represent 
mean molecule counts for 100 simulations. Lightly colored bands indicate standard 
deviation. RA: active PKMζ mRNA, P: PKMζ, AI: inserted GluA2-containing AMPARs, 
E1A: activated E1 enzyme. 
Although the spike of activated E1 enzyme releases the translational block of mRNA, 
resulting in a high level of activated PKMζ mRNA (RA in the model), translation is 
prevented by the protein synthesis inhibitor, and PKMζ synthesis is not initiated [9,37]. 
When the E1 enzyme returns to its inactive form the mRNA becomes repressed again, 
and the model remains in its unpotentiated state. Like the potentiated state, the 
unpotentiated state is very stable: No spontaneous potentiation events are observed 
even when running the model for a year of simulated time.  
 32 
 
By introducing a variable delay between stimulation and PSI infusion, we can study the 
model’s consolidation window, the time interval after induction during which PSI 
prevents establishment of L-LTP. As shown in Fig 5, when the delay before PSI infusion 
is 20 minutes or less, the model consistently settles in the lower (unpotentiated) steady 
state with zero or very few inserted GluA2-containing AMPARs. When the delay is 50 
minutes or more, the model settles in the upper (potentiated) state where the number of 
inserted GluA2-containing AMPARs fluctuates between ca 60 and 100 (cf. Fig 2). With 
intermediate delays, the probability of settling in the upper state gradually increases with 
increasing delay. The model’s consolidation window is thus in the range 30 to 45 
minutes, consistent with empirical results [11,12]. Fig 5 illustrates the model's bistable 
character: It settles either in the unpotentiated or potentiated state, never in the region 
with intermediate numbers of inserted GluA2-containing AMPARs. See also Fig 3 and 
Fig 4. 
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Fig 5: Consolidation window. Results of simulated NMDAR stimulation followed by 
PSI infusion after a delay varying from 0 to 60 minutes in 5-minute steps. One hundred 
simulations were run with each value for the delay. The number of inserted GluA2-
containing AMPARs was recorded twenty hours after stimulation. For each value of the 
delay, the heights of the columns indicate the number of simulations that terminated 
with the corresponding numbers of inserted GluA2-containing AMPARs. 
ZIP during and immediately after stimulation does not prevent L-LTP 
induction 
ZIP application during stimulation and the first 10 minutes thereafter after does not 
prevent L-LTP induction, (Fig 6). 
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Fig 6: ZIP immediately after stimulation does not prevent L-LTP induction. In this 
simulation, ZIP inhibits PKMζ activity during the first 10 minutes after stimulation. L-LTP 
induction is delayed somewhat compared to Fig 3, but enough active PKMζ mRNA 
remains when the ZIP is removed to trigger a transition to the potentiation state. Solid 
lines represent mean molecule counts for 100 simulations. Lightly colored bands 
indicate standard deviation. RA: active PKMζ mRNA, P: PKMζ, AI: inserted GluA2-
containing AMPARs, E1A: activated E1 enzyme. 
Presence of ZIP during the first ten minutes after stimulation does not prevent L-LTP 
induction [65]. The stimulation lifts the translational block and PKMζ production gets 
started. Even though PKMζ’s enzymatic activity is inhibited, the mRNA stays activated 
long enough to ride out the ZIP activity. When the ZIP is washed out, PKMζ becomes 
active and drives the synapse into its potentiated state. 
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PKMζ infusion induces L-LTP 
L-LTP can be induced by diffusion of PKMζ into a neuron [39,41]. We simulate infusion 
by rapidly increasing the number of PKMζ molecules in the synaptic compartment to 
100. This causes the model to settle into its potentiated state, (Fig 7). 
 
Fig 7: PKMζ infusion induces L-LTP. Infusion is simulated by stepping the PKMζ 
molecule count to 100 at “Inf”. The PKMζ lifts the translational inhibition of PKMζ mRNA, 
synthesis starts and the synapse switches to its potentiated state. Solid lines represent 
mean molecule counts for 100 simulations. Lightly colored bands indicate standard 
deviation. RA: active PKMζ mRNA, P: PKMζ, AI: inserted GluA2-containing AMPARs. 
PSI blocks PKMζ-infusion-induced potentiation 
The same level of PKMζ infusion that induces L-LTP in the previous experiment (100 
molecules) fails to do so in the presence of PSI (Fig 8). Although the PKMζ infusion 
initially causes a temporary increase in the number of inserted GluA2-containing 
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AMPARs, the PSI prevents replenishment to compensate for PKMζ degradation and 
dissipation and the model returns to its unpotentiated state. This result, though 
plausible, has not been demonstrated in a published experiment. It thus constitutes a 
prediction of the model. 
 
Fig 8: PSI blocks L-LTP induction by PKMζ infusion. As in Fig 7, infusion of PKMζ is 
simulated at “Inf”. PKMζ triggers activation of PKMζ mRNA as well as an increase of 
inserted GluA2-containing AMPARs, but in the absence of PKMζ synthesis (blocked by 
PSI), the PKMζ level declines and the synapse settles back into its unpotentiated state. 
Solid lines represent mean molecule counts for 100 simulations. Lightly colored bands 
indicate standard deviation. RA: active PKMζ mRNA, P: PKMζ, AI: inserted GluA2-
containing AMPARs. 
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PSI does not disrupt established L-LTP 
Fonseca et al. [12] demonstrated that suppressing protein synthesis for 100 minutes by 
bath application of anisomycin did not disrupt established L-LTP. Fig 9 shows the 
results of simulating this experiment in our model. The interruption of protein synthesis 
causes the number of PKMζ molecules to drop, which in turn leads to a transient 
decline in the number of inserted GluA2-containing AMPARs, but the system recovers 
when the PSI is removed. 
 
Fig 9: PSI infusion during the maintenance phase does not disrupt established L-
LTP. L-LTP is induced by NMDAR stimulation at “Stim”. Once L-LTP is established (100 
minutes after induction), protein synthesis inhibition is applied for 100 minutes. The 
interruption of kinase synthesis causes a decline in the levels of PKMζ and inserted 
GluA2-containing AMPARs, but the synapse recovers when the PSI is removed. Solid 
lines represent mean molecule counts for 100 simulations. Lightly colored bands 
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indicate standard deviation. RA: active PKMζ mRNA, P: PKMζ, AI: inserted GluA2-
containing AMPARs, E1A: activated E1 enzyme. 
If the model is correct, then the transient decrease in the number of GluA2-containing 
AMPARs may be detectable as a reduced EPSP current after PSI application. However, 
it is possible that the temporary removal of GluA2-containing AMPARs is compensated 
for by insertion of GluA2-lacking AMPARs, similarly to what has been shown to happen 
during retrieval-induced destabilization [45], in which case the synaptic strength would 
be maintained. If this is the case, then it may instead be possible to detect a transient 
increase in rectification index, because GluA2-lacking AMPARs, but not GluA2-
contaning ones, are characterized by a slight inward rectification [20,45]. Our model 
thus predicts that one or the other of these two effects (EPSP reduction or rectification) 
should be detectable after PSI application during L-LTP maintenance. 
Reactivation destabilizes, but does not disrupt, L-LTP 
The effect of memory reactivation is simulated as a brief spike in the amount of active 
E2 enzyme (Fig 10). This results in rapid endocytosis of the inserted GluA2-containing 
AMPARs [20,21] and release of the bound PKMζ molecules which then start to 
dissipate. However, due to continued synthesis, the PKMζ level is kept from dropping 
below threshold and the model settles back into the potentiated steady state [18,79].  
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Fig 10: Reactivation. NMDAR stimulation is simulated by a pulse of active E1 enzyme 
at “Stim”, and reactivation by a pulse of active E2 enzyme at “React”. E2A causes rapid 
endocytosis of GluA2-containing AMPARs, which in turn leads to PKMζ depletion. 
PKMζ mRNA only declines slowly, however, and the synapse returns to its potentiated 
state when the E2 enzyme deactivates. Solid lines represent mean molecule counts for 
100 simulations. Lightly colored bands indicate standard deviation. RA: active PKMζ 
mRNA, P: PKMζ, AI: inserted GluA2-containing AMPARs, E1A: activated E1 enzyme, 
E2A: activated E2 enzyme. 
Although the population of inserted GluA2-containing AMPARs is almost completely 
depleted after reactivation, the levels of PKMζ and active PKMζ mRNA stay well above 
their depotentiation thresholds and the model reliably recovers from post-reactivation 
instability (reconsolidation), unless challenged by simulated pharmacological 
interventions (see below). As mentioned earlier, Hong et al. demonstrated this abrupt 
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decrease of inserted GluA2-containing AMPARs after memory retrieval, as well as a 
corresponding transient increase of GluA2-lacking AMPARs, which maintained the 
synaptic strength during the labile period [20]. 
Reactivation followed by PSI disrupts L-LTP 
Simulation of PSI infusion simultaneously with reactivation, or shortly thereafter, causes 
disruption of L-LTP (Fig 11). 
 
Fig 11: Reactivation with simultaneous PSI infusion. As in Fig 10, reactivation is 
simulated as a pulse of active E2 enzyme at “React”, but here the presence of PSI 
prevents recovery and L-LTP is disrupted. Solid lines represent mean molecule counts 
for 100 simulations. Lightly colored bands indicate standard deviation. RA: active PKMζ 
mRNA, P: PKMζ, AI: inserted GluA2-containing AMPARs, E1A: activated E1 enzyme, 
E2A: activated E2 enzyme. 
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In the absence of new protein synthesis, the PKMζ level drops below threshold and the 
model settles into its unpotentiated state [18,79]. By varying the delay between 
reactivation and PSI infusion, we can establish the model’s reconsolidation window, the 
time interval after reactivation during which L-LTP is vulnerable to PSI. As shown in 
Fig 12, if PSI infusion is applied 15 minutes or less after reactivation, then the model 
reliably switches to its lower (unpotentiated) steady state with few inserted GluA2-
containing AMPARs, but with a delay of 30 minutes or more, L-LTP disruption does not 
result: the model remains in its potentiated state where the number of inserted GluA2-
containing AMPARs fluctuates in the 60-100 range. The model’s reconsolidation 
window is thus in the range 20 to 30 minutes, consistent with empirical results [18,84]. 
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Fig 12: Reconsolidation window. Results of simulated reactivation followed by PSI 
infusion. The delay between reactivation and PSI infusion is varied from 0 to 60 minutes 
in 5-minute steps. One hundred simulations were run with each value for the delay. The 
number of inserted GluA2-containing AMPARs was recorded twenty hours after 
stimulation. For each value of the delay, the heights of the columns indicate the number 
of simulations that terminated with the corresponding numbers of inserted AMPARs. 
GluA23Y blocks post-reactivation PSI-infusion from causing 
depotentiation 
When the GluA23Y peptide is infused together with PSI after reactivation, it prevents the 
disruption of L-LTP that PSI otherwise causes [57,63]. 
As before, reactivation triggers activation of the E2 enzyme, but here the GluA23Y 
peptide blocks its endocytotic effect. As a result, the GluA2-containing AMPARs remain 
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inserted and although the PSI stops synthesis of new PKMζ, the existing population of 
PKMζ molecules, bound to the inserted GluA2-containing AMPARs, declines at a slow 
enough rate to maintain the synapse in its potentiated state while the PSI wears off 
(Fig 13). 
 
Fig 13: Infusion of PSI and GluA23Y immediately after reactivation. In this simulation 
the endocytotic effect of the reactivation-triggered pulse of active E2 enzyme is blocked 
by GLUA23Y. As a result, the GluA2-containing AMPARs remain inserted and continue 
to sequester PKMζ molecules. The post-reactivation application of PSI still causes a 
decline in the level of PKMζ, but because of the low dissipation/degradation rate, the 
PKMζ level remains high enough that the L-LTP survives until the PSI wears off. Solid 
lines represent mean molecule counts for 100 simulations. Lightly colored bands 
indicate standard deviation. RA: active PKMζ mRNA, P: PKMζ, AI: inserted GluA2-
containing AMPARs, E1A: activated E1 enzyme, E2A: activated E2 enzyme. 
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ZIP infusion disrupts established L-LTP 
Infusion of ZIP during L-LTP maintenance causes rapid depotentiation [39–41]. ZIP 
inhibits PKMζ enzymatic activity, including both the catalysis of its own synthesis and 
the maintenance of an increased level of inserted GluA2-containing AMPARs in the 
PSD. The result is rapid removal of GluA2-containing AMPARs and depletion of PKMζ, 
and the synapse quickly settles into its unpotentiated state (Fig 14). The minimum 
duration of ZIP application needed to reliably disrupt L-LTP in the model is around 30 
minutes. 
 
Fig 14: ZIP infusion during L-LTP maintenance. Application of ZIP inhibits PKMζ’s 
enzymatic activity, leading to rapid depotentiation. Solid lines represent mean molecule 
counts for 100 simulations. Lightly colored bands indicate standard deviation. RA: active 
PKMζ mRNA, P: PKMζ, AI: inserted GluA2-containing AMPARs, E1A: activated E1 
enzyme. 
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GluA23Y blocks depotentiation by ZIP infusion 
When the GluA23Y peptide is infused together with ZIP during L-LTP maintenance, the 
disruptive effect of ZIP is blocked [33]. 
As before, ZIP inhibits PKMζ’s catalysis of its own synthesis as well as its facilitation of 
AMPAR trafficking into the PSD and its blocking effect on BRAG2-induced endocytosis 
of GluA2-containing AMPAR. But in this case, even though BRAG2 remains active, the 
presence of GluA23Y prevents it from inducing endocytosis of the inserted GluA2-
containing AMPARs. As a result, the GluA2-containing AMPARs remain in the PSD and 
continue to maintain the PKMζ molecules at the synapse. The number of PKMζ 
molecules declines only slowly and the potentiation is able to survive through the 12-
hour period of ZIP activity (Fig 15). 
 
Fig 15: Infusion of ZIP and GluA23Y during L-LTP maintenance. ZIP blocks PKMζ’s 
enzymatic activity: PKMζ mRNA returns to its untranslatable state, and BRAG2 
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becomes active. However, GluA23Y prevents BRAG2 from inducing GluA2-containing 
AMPAR endocytosis, the PKMζ molecules remain attached to the inserted AMPARs, 
and the catastrophic disruption of L-LTP seen in Fig 14 is averted. Solid lines represent 
mean molecule counts for 100 simulations. Lightly colored bands indicate standard 
deviation. RA: active PKMζ mRNA, P: PKMζ, AI: inserted GluA2-containing AMPARs, 
E1A: activated E1 enzyme. 
Discussion 
The model presented here is able to explain a range of results relating to the role of 
PKMζ in late-phase long-term synaptic potentiation, including L-LTP induction by 
NMDAR stimulation or by PKMζ infusion and the findings that whereas PSI, but not ZIP, 
can block induction of L-LTP, the reverse is true for disruption of established L-LTP. In 
addition, it accounts for cellular reconsolidation, reconsolidation blockade by PSI 
infusion and prevention of ZIP- or PSI-induced depotentiation by infusion of the GluA23Y 
peptide. While subsets of these results have been covered by earlier models [85–89], 
ours is the first to account for all of them. A further distinguishing feature of our model is 
that it demonstrates that a wide range of empirical findings described in the LTP 
literature can be accounted for by simple molecular reactions whose rates are governed 
only by the law of mass action, i.e. without postulating cooperative binding or other non-
linear dependencies on reactant concentrations. 
Our model demonstrates that a bistable mechanism for synaptic potentiation can arise 
from the interaction of two coupled feedback loops, neither of which needs itself be 
bistable. One of these, the mutual reinforcement between PKMζ and PKMζ mRNA, has 
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been featured in previously published models of L-LTP maintenance [85–88]. The 
second positive feedback relationship in our model is between PKMζ and inserted 
GluA2-containing AMPARs, which mutually maintain each other by inhibiting each 
other’s removal from the synapse [42]. The ability of inserted AMPARs to sequester 
PKMζ molecules at the synapse allows the model to account for findings involving the 
inhibition of regulated endocytosis of GluA2-containing AMPAR [33,57].  
Our model exhibits robust bistability; when left to run for a full year of simulated time in 
either the potentiated or depotentiated state, no spontaneous transitions between the 
steady-states were observed. The source of this bistability can be understood by 
considering the interaction between the two feedback loops. The PKMζ-mRNA 
interaction is a positive feedback loop: A greater number of PKMζ molecules will keep 
more mRNA molecules in an unrepressed state and more unrepressed mRNA results in 
a higher rate of PKMζ synthesis. This subsystem has two steady states: a lower steady 
state with zero PKMζ molecules and zero unrepressed mRNA molecules, and a higher 
state at a level that depends on the reaction rates, in particular PKMζ’s dissipation rate, 
because at equilibrium the synthesis and dissipation rates are equal. The lower steady 
state is unstable; the introduction of just a few PKMζ molecules can cause a switch to 
the upper state. The PKMζ – mRNA feedback loop thus has only a single stable steady 
state which depends on the PKMζ dissipation rate, as illustrated in Fig 16. 
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Fig 16: PKMζ level at steady state as a function of dissipation rate. The solid line 
represents a stable steady state, and the dashed line an unstable steady state. The x-
axis represents the reaction constant for PKMζ dissipation/degradation. “C8” indicates 
the value used for the reaction constant of reaction 8, dissipation/degradation of 
unbound PKMζ. “E” indicates the effective dissipation rate in the potentiated state, when 
a large proportion of the PKMζ molecules are bound to inserted GluA2-containing 
AMPARs. 
Bistability arises because of the influence of the second feedback loop, the interaction 
between PKMζ and GluA2-containing AMPARs. In the unpotentiated state, the PKMζ 
dissipation/degradation rate is controlled by the reaction constant c8, which has a value 
of 0.5. As seen in Fig 16, the steady state at this rate has zero PKMζ molecules. In the 
potentiated state, an increased number of GluA2-containing AMPARs in the PSD bind 
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PKMζ molecules; this results in a reduction of the effective PKMζ 
dissipation/degradation rate to a value where the steady state has ca 100 PKMζ 
molecules (indicated by ‘E’ in Fig 16).  
Comparison with previous computational models of PKMζ regulation 
Clopath et al. [89] describe a mathematical model of synaptic tagging and capture 
(STC) [90], wherein mechanisms of tag-setting and triggering of protein synthesis 
interact with a bistable process that maintains potentiation. Although the authors 
suggest that one of the model’s parameters may represent the level of PKMζ activity, 
the mechanisms of the process are unspecified, and the model therefore cannot 
account for the results targeted by our model: the effects of PSI, ZIP and GluA23Y in the 
contexts of L-LTP induction and maintenance, or of memory reactivation. 
A simple model by Ogasawara and Kawato [86] simulates L-LTP induction and 
maintenance as well as reconsolidation based on the interactions of only three 
molecules: PKMζ, PKMζ mRNA and F-Actin. It is, however, not able to account for most 
of the results addressed in this paper. 
A paper by Zhang et al. [88] features a dual-loop model of LTP that exhibits windows of 
susceptibility to PSI after induction and reactivation as well as vulnerability to a kinase 
inhibitor in the maintenance phase. The relationship between the kinase and AMPA 
receptors is not modeled, and thus the ability of an endocytosis blocker like GluA23Y to 
rescue L-LTP is not accounted for. Also, the kinase modeled in [88] is unnamed but 
characterized by auto-activation rather than persistent activity, and should therefore 
probably not be interpreted as PKMζ.  
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Smolen et al. [87] model synaptic tagging and capture, including “cross-tagging” 
between LTP and LTD. As in our model, synaptic stability is based on PKMζ’s ability to 
catalyze its own synthesis. Unlike our model, [87] does not account for the effects of 
protein synthesis inhibition, kinase inhibition, reactivation or the ability of endocytosis 
blocking to rescue L-LTP. 
A paper by Jalil et al. [85] models PKMζ regulation at the synapse, with a focus on 
compensatory interactions between PKMζ and a second atypical PKC isoform, PKCι/λ. 
Bistability is achieved by combining the PKMζ auto-catalytic synthesis feedback loop 
with auto-phosphorylation. The model predicts the differential effects of ZIP and PSI at 
L-LTP induction and maintenance, but does not account for L-LTP rescue by AMPAR 
endocytosis blocking, nor for reconsolidation.  
Limitations 
Our model represents a subset of the mechanisms believed to be involved in LTP 
induction and maintenance [3,91]. Some processes not included in our model are: 
 the induction and stabilization of early LTP, which likely involves GluA2-lacking 
AMPARs [45], the MAPK/ERK  signaling pathway and the proteins PKA, CaMKII 
[91] and PKCλ [65,92] 
 a later phase of L-LTP, sometimes called LTP3, which requires gene 
transcription as well as mRNA translation [93] and may involve a “tagging and 
capture” mechanism for selectively targeting gene products to potentiated 
synapses [40,90].  
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 polymerization/depolymerization of actin and restructuring of the cytoskeleton 
[94,95]  
The processes that we have modeled thus form a subset of a more complex machinery. 
Nevertheless, it is interesting to note that this relatively simple model is able to account 
for many of the empirical findings regarding the role of PKMζ in L-LTP induction and 
maintenance, and to exhibit the degree of stability required for a neural mechanism to 
support long-lasting memories. 
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